Giuseppe Giaccone, PhD, MD, comments on the incidence of HLA-A2 positive (NSCLC) - YouTube
Dr. Giaccone on Investigational Agents in Thymic Cancers
Dr. Giuseppe Giaccone | Mesothelioma Expert in New York
Loop | Giuseppe Giaccone
Dr. Giuseppe Giaccone, MD - Hematology & Oncology Specialist in New York, NY | Healthgrades
Giuseppe Giaccone, PhD, MD, speculates on next steps in the development of Tedopi (OSE2101) - YouTube
Giuseppe VIALE | Professor (Full) | MD, FRCPath | University of Milan, Milan | UNIMI | Department of Oncology and hemato-oncology; European Institute of Oncology | Research profile
Research in a Minute: Dr. Giuseppe Giaccone - YouTube
Giuseppe Giaccone, Ph.D., M.D. at Lung Cancer and Thoracic Oncology Program: Hematology/Oncology | NewYork-Presbyterian Doctor in New York, NY
Dr. Giaccone on Investigational Agents in Thymic Cancers
Dr. Giaccone on Treatment Options in NSCLC
Dr. Giuseppe Giaccone, MD - Hematology & Oncology Specialist in New York, NY | Healthgrades
Precision Medicine Pioneer Pursues New Cancer Treatments | Georgetown University Medical Center | Georgetown University
Atezolizumab bests chemo in NSCLC patients with high PD-L1 expression | MDedge Hematology and Oncology
ITMIG 2017# Interview with Dr. Giuseppe Giaccone: We should focus on data, and keep up-to-date - YouTube
Dramatic Response to Sequential BRAF Inhibition in BRAF V600E–Mutant Metastatic Lung Adenocarcinoma | JCO Precision Oncology
Dr. Giaccone on Treatment Options in NSCLC
Giuseppe Giaccone, MD PhD, National Cancer Institute on Vimeo
Loop | Giuseppe Giaccone
Loop | Giuseppe Giaccone
Dr. Giuseppe Giaccone, MD, PhD | New York, NY | Oncologist
Dr. Giaccone on Treatment Options in NSCLC | Giuseppe Giaccone, MD, PhD, of Weill Cornell Medicine discusses current treatment options in non–small cell lung cancer. https://bit.ly/32ELJ2F | By OncLive | Facebook
Dr. Ashish Saxena, MD – New York, NY | Oncology
Research in a Minute: Dr. Giuseppe Giaccone - YouTube
